NeoGenomics, Inc.
(NASDAQ : NEO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Services » Medical Or Nursing Services
symbolcompany%chnglast%shortavg$volume
TDOCTeladoc Health, Inc. -3.36%27.028.2%$119.04m
DVADaVita, Inc. -1.29%86.364.3%$61.71m
DNAGinkgo Bioworks Holdings, Inc. -5.25%2.800.0%$61.12m
AGLAgilon Health, Inc. -0.05%22.440.0%$60.30m
ONEM1Life Healthcare, Inc. -0.29%17.100.0%$52.20m
NTRANatera, Inc. -5.48%43.641.1%$49.36m
CANOCano Health, Inc. 6.48%8.880.0%$48.77m
ACHCAcadia Healthcare Co., Inc. -1.56%77.7926.5%$48.58m
OSHOak Street Health, Inc. -5.65%24.740.0%$47.68m
GHGuardant Health, Inc. -1.75%48.960.0%$40.37m
LHCGLHC Group, Inc. 0.09%164.663.0%$39.06m
PRVAPrivia Health Group, Inc. -0.72%34.410.0%$36.86m
EHCEncompass Health Corp. -0.71%47.730.0%$33.65m
OPCHOption Care Health, Inc. -2.07%29.740.0%$31.08m
AMEDAmedisys, Inc. -1.57%106.1111.5%$30.97m

Company Profile

NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. It operates through the Clinical Services and Pharma Services segments. The Clinical Services segment offers cancer testing services to community-based pathologists, hospitals, academic centers, and oncology groups. The Pharma Services segment focuses on supporting pharmaceutical firms in drug development programs by supporting various clinical trials and research. It also provides testing services in support of its pharmaceutical clients' oncology programs from discovery to commercialization. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.